Position in MRNA
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$827,264
+$231,431 QoQ
Shares Held
11,813
+0.7% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
#324
of 777 holders
Holding Since
Sep 2023
11 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in MRNA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Annis Gardner Whiting Capital Advisors, LLC holds $3,719,923 across 6 Biotechnology names. MRNA ranks #3 (22.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IONS |
Ionis Pharmaceuticals Inc
|
12,801 | $1,014,991 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,953 | $970,113 | |
| 3 | MRNA |
Moderna, Inc.
This page
|
11,813 | $827,264 | |
| 4 | IOVA |
Iovance Biotherapeutics, Inc.
|
100,470 | $417,955 | |
| 5 | EPRX |
Eupraxia Pharmaceuticals Inc.
|
60,000 | $396,600 | |
| 6 | EVAX |
Evaxion A/S
|
30,000 | $93,000 |
All Filings in MRNA
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $827,264 | 11,813 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $595,833 | 11,729 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $345,416 | 11,713 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $300,945 | 11,651 | Shares | Sole | 2025-11-03 | |
| 2025-06-30 | $293,943 | 10,654 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $213,447 | 7,529 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $226,236 | 5,441 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $315,170 | 4,716 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $525,231 | 4,423 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $319 | 3 | Shares | Sole | 2024-05-13 | |
| 2023-09-30 | $2,478 | 24 | Shares | Sole | 2023-11-08 | |
| No filing history on record for this holder in this stock. | ||||||